Keep off the grass: Marijuana use and acute cardiovascular events

European Journal of Emergency Medicine

Volumn 12, Issue 5, 2005, Pages 236-244

  Caldicott, David G E ^a   Holmes, James ^a   Roberts Thomson, Kurt C ^a   Mahar, Leo ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cannabis; Infarction; Ischaemia; Keywords; Marijuana

Indexed keywords

CANNABIS; STREET DRUG;

ACUTE DISEASE; ADULT; AGE; ANGIOCARDIOGRAPHY; CASE REPORT; CHEMICALLY INDUCED DISORDER; HEART INFARCTION; HUMAN; MALE; RADIOGRAPHY; REVIEW; RISK FACTOR;

ACUTE DISEASE; ADULT; AGE FACTORS; CANNABIS; CORONARY ANGIOGRAPHY; HUMANS; MALE; MYOCARDIAL INFARCTION; RISK FACTORS; STREET DRUGS;

EID: 33644834151     PISSN: 09699546     EISSN: 14735695     Source Type: Journal    
DOI: 10.1097/00063110-200510000-00008     Document Type: Article

References (80)

1. Australian Institute of Health and Welfare. 2001 National Drug Strategy Household Survey; first results. Canberra, Australia. AIHW cat. no. PHE 35; 2002.
2. Substances Abuse and Mental Health Services Administration (SAMHSA). National Survey on Drug Use and Health, 2002. Washington, District of Columbia, USA: Office of Applied Studies, US Department of Health & Human Services; 2002.
3. Contenau J. La divination chez les Assyriens et les Babyloniens. Paris: Payot, 1940.
4. Room A. Brewers dictionary of phrase and Fable. Millenium edn. London: Cassel Publishing Ltd; 1999. p. 67.
5. Baker D, Pryce G, Giovannoni G, Thompson AJ. The therapeutic potential of cannabis. Lancet Neurol 2003; 2:291-298.
6. Anonymous. British Home Office Circular 05/2004. London: UK Government; 2004.
7. Dewey WL. Cannabinoid pharmacology. Pharmacol Rev 1986; 38:151-178.
8. Isbell H, Gorodetzsky CW, Jasinski D, Claussen U, von Spulak F, Korte F. Effects of (-)delta-9-trans-tetrahydrocannabinol in man. Psychopharmacologia 1967; 11:184-188.
9. Hall W, Swift W. The THC content of cannabis in Australia: evidence and implications. Aust NZ J Public Health 2000; 24:503-508.
10. Kunos G, Batkai S. Novel physiologic functions of endocannabinoids as revealed through the use of mutant mice. Neurochem Res 2001; 26:1015-1021.
11. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 1999; 283:401-404.
12. Jarai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, et al. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA 1999; 96:14136-14141.
13. Wagner JA, Varga K, Jarai Z, Kunos G. Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension 1999; 33(Pt 2):429-434.
14. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson WA, Griffin G, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992; 258:1946-1949.
15. Sugiura T, Kondo S, Sukagawa A, Tonegawa T, Nakane S, Yamashita A, et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 1995; 215:89-97.
16. Schwarz CJ. Toward a medical understanding of marihuana. Can Psychiatr Assoc J 1969; 14:591-600.
17. Johnson S, Domino EF. Some cardiovascular effects of marihuana smoking in normal volunteers. Clin Pharmacol Ther 1971; 12:762-768.
18. Weiss JL, Watanabe AM, Lemberger L, Tamarkin NR, Cardon PV. Cardiovascular effects of delta-9-tetrahydrocannabinol in man. Clin Pharmacol Ther 1972; 13:671-684.
19. Beaconsfield P, Ginsburg J, Rainsbury R. Marihuana smoking. Cardiovascular effects in man and possible mechanisms. N Engl J Med 1972; 287:209-212.
20. Cannabis and the cardiovascular system. J am med assoc 1973; 225:58.
21. Li DM. Cardiovascular and respiratory effects of cannabis extracts and 1-tetra-hydrocannabinol (1-THC). Br J Pharmacol 1973; 47:627P.
22. Clark SC, Greene C, Karr GW, MacCannell KL, Milstein SL. Cardiovascular effects of marihuana in man. Can J Physiol Pharmacol 1974; 52:706-719.
23. Vollmer RR, Cavero I, Ertel RJ, Solomon TA, Buckley JP. Role of the central autonomic nervous system in the hypotension and bradycardia induced by (-)-delta 9-trans-tetrahydrocannabinol. J Pharm Pharmacol 1974; 26:186-192.
24. Varga K, Lake KD, Huangfu D, Guyenet PG, Kunos G. Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension 1996; 28:682-686.
25. Dewey WL, Jenkins J, O’Rourke T, Harris LS. The effects of chronic administration of trans-9-tetrahydrocannabinol on behavior and the cardiovascular system of dogs. Arch Int Pharmacodyn Ther 1972; 198:118-131.
26. Kunos G, Jarai Z, Varga K, Liu J, Wang L, Wagner JA. Cardiovascular effects of endocannabinoids - the plot thickens. Prostaglandins Other Lipid Mediat 2000; 61:71-84.
27. Kochar MS, Hosko MJ. Electrocardiographic effects of marihuana. J am med assoc 1973; 225:25-27.
28. Wagner JA, Varga K, Ellis EF, Rzigalinski BA, Martin BR, Kunos G. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature 1997; 390:518-521.
29. Maykut MO. Health consequences of acute and chronic marihuana use. Prog Neuropsychopharmacol Biol Psychiatry 1985; 9:209-238.
30. Hollister LE. Health aspects of cannabis. Pharmacol Rev 1986; 38:1-20.
31. Aronow WS, Cassidy J. Effect of marihuana and placebo-marihuana smoking on angina pectoris. N Engl J Med 1974; 291:65-67.
32. Aronow WS, Cassidy J. Effect of smoking marihuana and of a high-nicotine cigarette on angina pectoris. Clin Pharmacol Ther 1975; 17:549-554.
33. Charles R, Holt S, Kirkham N. Myocardial infarction and marijuana. Clin Toxicol 1979; 14:433-438.
34. MacInnes DC, Miller KM. Fatal coronary artery thrombosis associated with cannabis smoking. J R Coll Gen Pract 1984; 34:575-576.
35. Collins JS, Higginson JD, Boyle DM, Webb SW. Myocardial infarction during marijuana smoking in a young female. Eur Heart J 1985; 6:637-638.
36. Choi YS, Pearl WR. Cardiovascular effects of adolescent drug abuse. J Adolesc Health Care 1989; 10:332-337.
37. Podczeck A, Frohmer K, Steinbach K. Marijuana as a cause of myocardial infarction. Int J Cardiol 1990; 34:353-354.
38. McLeod AL, McKenna CJ, Northridge DB. Myocardial infarction following the combined recreational use of Viagra and cannabis. Clin Cardiol 2002; 25:133-134.
39. Bachs L, Morland H. Acute cardiovascular fatalities following cannabis use. Forens Sci Int 2001; 124:200-203.
40. Rezkalla SH, Sharma P, Kloner RA. Coronary no-flow and ventricular tachycardia associated with habitual marijuana use. Ann Emerg Med 2003; 42:365-369.
41. Mouzak A, Agathos P, Kerezoudi E, Mantas A, Vourdeli-Yiannakoura E. Transient ischemic attack in heavy cannabis smokers - how ‘safe’ is it? Eur Neurol 2000; 44:42-44.
42. Lawson TM, Rees A. Stroke and transient ischaemic attacks in association with substance abuse in a young man. Postgrad Med J 1996; 72:692-693.
43. Cooles P, Michaud R. Stroke after heavy cannabis smoking. Postgrad Med J 1987; 63:511.
44. Zachariah SB. Stroke after heavy marijuana smoking. Stroke 1991; 22:406-409.
45. Barnes D, Palace J, O’Brien MD. Stroke following marijuana smoking. Stroke 1992; 23:1381.
46. McCarron MO, Thomas AM. Cannabis and alcohol in stroke. Postgrad Med J 1997; 73:448.
47. White D, Martin D, Geller T, Pittman T. Stroke associated with marijuana abuse. Pediatr Neurosurg 2000; 32:92-94.
48. Marinella MA. Stroke after marijuana smoking in a teenager with factor V Leiden mutation. South Med J 2001; 94:1217-1218.
49. Herning RI, Better WE, Tate K, Cadet JL. Marijuana abusers are at increased risk for stroke. Preliminary evidence from cerebrovascular perfusion data. Ann NY Acad Sci 2001; 939:413-415.
50. Alvaro LC, Iriondo I, Villaverde FJ. Sexual headache and stroke in a heavy cannabis smoker. Headache 2002; 42:224-226.
51. Russmann S, Winkler A, Lovblad KO, Stanga Z, Bassetti C. Lethal ischemic stroke after cisplatin-based chemotherapy for testicular carcinoma and cannabis inhalation. Eur Neurol 2002; 48:178-180.
52. Vaziri ND, Thomas R, Sterling M, Seiff K, Pahl MV, Davila J, et al. Toxicity with intravenous injection of crude marijuana extract. Clin Toxicol 1981; 18:353-366.
53. Lambrecht GL, Malbrain ML, Coremans P, Verbist L, Verhaegen H. Acute renal infarction and heavy marijuana smoking. Nephron 1995; 70:494-496.
54. Sterne J, Ducastaing G. Les arterites du cannabis indica. Arch Maladies Coeur Vaiseaux 1960; 53:143-147.
55. Citron BP, Halpern M, McCarron M, Lundberg GD, McCormick R, Pincus JJ, et al. Necrotizing angiitis associated with drug abuse. N Engl J Med 1970; 283:1003-1011.
56. Disdier P, Swiader L, Jouglard J, Piquet P, Christides C, Moulin G, et al. Cannabis-induced arteritis vs. Leo Buerger disease. Nosologic discussion apropos of two new cases. Presse Med 1999; 28:71-74.
57. Disdier P, Granel B, Serratrice J, Constans J, Michon-Pasturel U, Machulla E, et al. Cannabis arteritis revisited - ten new case reports. Angiology 2001; 52:1-5.
58. Groger A, Aslani A, Wolter T, Noah EM, Pallua N. A rare case of cannabis arteritis. Vasa 2003; 32:95-97.
59. Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation 2001; 103:2805-2809.
60. Moussouttas M. Cannabis use and cerebrovascular disease. Neurologist 2004; 10:47-53.
61. Mesec A, Rot U, Grad A. Cerebrovascular disease associated with marijuana abuse: a case report. Cerebrovasc Dis 2001; 11:284-285.
62. Kosior DA, Filipiak KJ, Stolarz P, Opolski G. Paroxysmal atrial fibrillation in a young female patient following marijuana intoxication - a case report of possible association. Med Sci Monit 2000; 6:386-389.
63. Maccarrone M, Bari M, Principe DD, Finazzi-Agro A. Activation of human platelets by 2-arachidonoylglycerol is enhanced by serotonin. Thromb Haemost 2003; 89:340-347.
64. Burns CB, Ivers RG, Lindorff KJ, Clough AR. Cannabis: a Trojan horse for nicotine? Aust NZ J Public Health 2000; 24:637.
65. Cumpston K, O’Koren K, Wahl M. The ecstasy and misery of a teenage myocardial infarction (abst). J Toxicol Clin Toxicol 2002;40:655.
66. Ment J, Ludman PF. Coronary thrombus in a 23 year old anabolic steroid user. Heart 2002; 88:342.
67. James LP, Farrar HC, Komoroski EM, Wood WR, Graham CJ, Bornemeier RA, et al. Sympathomimetic drug use in adolescents presenting to a pediatric emergency department with chest pain. J Toxicol Clin Toxicol 1998; 36:321-328.
68. Gowda RM, Khan IA, Vasavada BC, Sacchi TJ. Alcohol-triggered acute myocardial infarction. Am J Ther 2003; 10:71-72.
69. Wilkins MR, Kendall MJ. Stroke affecting young men after alcoholic binges. Br Med J (Clin Res Ed) 1985; 291:1342.
70. Spector I. AMP: a new form of marijuana. J Clin Psychiatry 1985; 46:498-499.
71. Mendyk SL, Fields DW. Acute psychotic reactions: consider ‘dip dope’ intoxication. J Emerg Nurs 2002; 28:432-435.
72. Sztajzel J, Mach F, Righetti A. Role of the vascular endothelium in patients with angina pectoris or acute myocardial infarction with normal coronary arteries. Postgrad Med J 2000; 76:16-21.
73. Seniuk W, Mularek-Kubzdela T, Grygier M, Grajek S, Cieslinski A. Cardiac arrest related to coronary spasm in patients with variant angina: a three-case study. J Intern Med 2002; 252:368-376.
74. Osula S, Bell GM, Hornung RS. Acute myocardial infarction in young adults: causes and management. Postgrad Med J 2002; 78:27-30.
75. Chandrasekaran B, Kurbaan A. Myocardial infarction with angiographically normal coronary arteries. J R Soc Med 2002; 95:398-400.
76. Gupta B, Jani C, Shah PH. Fatal ‘Bhang’ poisoning. Med Sci Law 2001; 41:349-352.
77. Geller T, Loftis L, Brink DS. Cerebellar infarction in adolescent males associated with acute marijuana use. Pediatrics 2004; 113:e365-e370.
78. Germing A, Lindstaedt M, Ulrich S, Grewe P, Bojara W, Lawo T, et al. Normal angiogram in acute coronary syndrome-preangiographic risk stratification, angiographic findings and follow-up. Int J Cardiol 2005; 99:19-23.
79. Lee CH, Tan HC, Teo SG, Sutandar A, Lim YT. Safety and feasibility of X-sizer-facilitated rescue percutaneous coronary intervention: a preliminary experience. J Invasive Cardiol 2005; 17:1-4.
80. Lorin JD, Liou MC, Sedlis SP. Rapid thrombectomy for treatment of macroembolization during percutaneous coronary intervention in the setting of acute myocardial infarction. Catheter Cardiovasc Interv 2003; 59:219-222.